Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-05-24Clinical Trial Update: Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia Patients [Phase 2]
Phase 2 trial evaluating paliperidone extended-release tablets versus placebo on sleep in schizophrenia patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-19Clinical Trial Update: Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia [Phase 3]
Phase 3 safety and tolerability study of ziprasidone in adolescents with schizophrenia was terminated; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: Promoting Adherence to Treatment in Schizophrenia [NA]
A completed clinical trial conducted by UCLA focusing on strategies to promote adherence to schizophrenia treatment.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: Treatment of Schizophrenic Patients With Ziprasidone
Completed clinical trial evaluating ziprasidone for schizophrenia with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Clozapine and Olanzapine Treatment of Aggression [NA]
This completed clinical trial evaluated whether clozapine and olanzapine can reduce aggression in individuals with schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-05-13FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) by Janssen Pharmaceuticals, updating the labeling for t…
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712 [Phase 1]
This Phase 1 PET imaging study evaluated brain pharmacokinetics and occupancy after a single oral dose of OPC-34712 in individuals with schi…
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia [Phase 1]
This report covers a completed Phase 1 study evaluating the H1-coil Deep Transcranial Magnetic Stimulation for negative symptoms and cogniti…
-
FDA approval · 2010-04-30FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine by Mylan Pharmaceuticals, updating labeling for the generic antipsychotic.
-
FDA approval · 2010-04-27FDA Approved: RISPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for risperidone from ANI Pharmaceuticals, Inc., under an ANDA.
-
FDA approval · 2010-04-27FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia [Phase 3]
Phase 3 trial of intramuscular paliperidone palmitate injections in the arm or buttock for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone [Phase 3]
An open-label Phase 3 study evaluated whether switching adults with schizophrenia from risperidone tablets to an equivalent dose of a rapidl…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate [Phase 1]
Phase 1 study reporting blood concentrations of paliperidone after administration of paliperidone palmitate in schizophrenia patients; the t…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres [Phase 4]
Phase 4 clinical trial assessing symptomatic remission in schizophrenia using long-acting risperidone microspheres; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Registry of Treatment Adherence for Patients With Schizophrenia
A completed registry-style clinical trial sponsored by Janssen-Cilag, S.A. evaluating treatment adherence in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. [Phase 4]
This Phase 4 study evaluated three strategies for switching patients with schizophrenia or schizoaffective disorder from olanzapine to rispe…
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. [Phase 1]
A Phase 1 bioequivalence study comparing two formulations of a 4 mg risperidone tablet has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients [Phase 4]
This clinical trial update reports a Phase 4 trial evaluating amisulpride augmentation therapy for clozapine-resistant schizophrenia, with t…
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward [Phase 4]
A Phase 4 trial comparing Zotepine and Risperidone in aggressive schizophrenia patients in an acute ward was terminated.
-
FDA approval · 2010-04-15FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2010-04-14Clinical Trial Update: The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia [Phase 4]
Phase 4 clinical trial update investigating pharmacogenetics, readiness to change, and pharmacological smoking cessation in individuals with…
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia [Phase 3]
Phase 3 trial of ziprasidone in adolescents with schizophrenia was terminated; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: Training-induced Cerebral Reorganization in Schizophrenia [NA]
This completed clinical trial reports on training-induced cerebral reorganization in individuals with schizophrenia.
-
CLINICAL_TRIALS research · 2010-04-08Clinical Trial Update: Shared Decision Making for Schizophrenia [NA]
A completed clinical trial (NCT00220870) conducted in Munich investigated shared decision making for schizophrenia. The status is listed as …